11 employees
Equinox is a developer of a medical technology in revolutionizing the treatment of glaucoma and other progressive eye diseases.
2015
$15M
from 1 investors over 1 rounds
Equinox Ophthalmic, Inc. raised $15M on March 31, 2018
Investors: Visionary Venture Fund